Skip to main content

Table 2 Changes of ferrokinetic parameters and bilirubin levels in the patient’s serum during bloodletting therapy

From: Diagnosis and treatment of a 16-year-old Chinese patient with concurrent hereditary hemochromatosis and Gilbert's syndrome

Follow-up

Bloodletting therapy

TBIL (μmol/L)

DBIL (μmol/L)

Serum iron (μmol/L)

Transferrin (mg/dL)

Ferritin (ng/mL)

0

0

61.80

7.50

39.42

187.00

410.02

1

300 mL/week

105.60

9.80

40.07

155.00

424.19

2

400 mL/week

41.70

7.40

7.97

224.00

324.51

3

400 mL/week

37.20

7.60

8.42

234.00

333.68